SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,045,000 | +55.4% | 7,000,000 | 0.0% | 0.13% | +34.3% |
| Q3 2022 | $1,960,000 | -9.5% | 7,000,000 | +16.5% | 0.10% | -13.2% |
| Q2 2022 | $2,165,000 | +7.7% | 6,011,005 | +100.4% | 0.11% | +56.2% |
| Q1 2022 | $2,010,000 | -48.1% | 3,000,000 | 0.0% | 0.07% | -60.1% |
| Q4 2021 | $3,870,000 | -40.6% | 3,000,000 | 0.0% | 0.18% | +0.5% |
| Q3 2021 | $6,510,000 | -20.5% | 3,000,000 | 0.0% | 0.18% | -64.7% |
| Q2 2021 | $8,190,000 | +25.5% | 3,000,000 | +20.0% | 0.52% | +35.2% |
| Q1 2021 | $6,526,000 | +0.5% | 2,500,418 | +7.1% | 0.38% | -20.1% |
| Q4 2020 | $6,492,000 | – | 2,335,200 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,126,000 | $754,000 | 0.72% |
| Prosight Management, LP | 670,300 | $449,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $3,962,000 | 0.12% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $98,000 | 0.10% |
| Rubric Capital Management LP | 3,000,000 | $2,010,000 | 0.07% |
| Clearline Capital LP | 392,691 | $263,000 | 0.03% |
| APOGEM CAPITAL LLC | 49,528 | $33,000 | 0.02% |
| Hudson Bay Capital Management LP | 1,682,000 | $1,127,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,900 | $164,000 | 0.00% |
| NORTHERN TRUST CORP | 87,153 | $58,000 | 0.00% |